ライフサイエンスコーパス: hospital readmission

1 The primary outcome was 30-day unplanned hospital readmission.

2 p = 0.04) were independently associated with hospital readmission.

3 minor complications, failure to rescue, and hospital readmission.

4 Heart failure (HF) is the leading cause for hospital readmission.

5 or patients who underwent surgery who needed hospital readmission.

6 ength of hospital stay and time to all-cause hospital readmission.

7 1.25]) were associated with a higher risk of hospital readmission.

8 atisfaction and either major complication or hospital readmission.

9 ins were associated with hazard of all-cause hospital readmission.

10 Patients with ESRD are at high risk for hospital readmission.

11 y (SNF) performance measures and the risk of hospital readmission.

12 ications, is associated with a lower risk of hospital readmission.

13 as associated with less late NIV failure and hospital readmission.

14 a tipping point exists for LOS reduction and hospital readmission.

15 ospital mortality, short-term mortality, and hospital readmission.

16 time, with higher risks of complications and hospital readmission.

17 with an increased likelihood of an inpatient hospital readmission.

18 h anemia, AKI, post-discharge mortality, and hospital readmission.

19 The primary outcome was unplanned 30-day hospital readmission.

20 , an uneventful postoperative course, and no hospital readmission.

21 ergency hospital resource use, and emergency hospital readmission.

22 of tracheostomy, 60.3% of patients required hospital readmission.

23 (83%) reporting greater than or equal to one hospital readmission.

24 rate for the combined end point of death and hospital readmission.

25 cluding length of stay (LOS), mortality, and hospital readmission.

26 talization, nonroutine discharge status, and hospital readmission.

27 n the usual care group, but no difference in hospital readmissions.

28 e events, overall serious adverse events, or hospital readmissions.

29 ontributor to excess healthcare costs due to hospital readmissions.

30 alth care reform has been on reducing 30-day hospital readmissions.

31 that this reduction may result in increased hospital readmissions.

32 rstand frequency and factors associated with hospital readmissions.

33 vement on any variables except self-harm and hospital readmissions.

34 suicide attempts, and rates and duration of hospital readmissions.

35 lure trials, when compared with mortality or hospital readmissions.

36 postdischarge mortality related to reducing hospital readmissions.

37 and does not result in higher-than-expected hospital readmissions.

38 h outcomes and a positive effect on reducing hospital readmissions.

39 ortality (45 [2.0] vs 37 [1.6]; P = .23) and hospital readmissions (107 [4.9] vs 103 [4.4]; P = .42)

40 ex admission (-$11 [95% CI, -$278 to $257]), hospital readmission ($245 [95% CI, -$231 to $721]), or

41 to hypotension (13% vs. 6%), or 30-day death/hospital readmission (33% vs. 25%).

42 % vs 5.7%, P = 0.001), and procedure-related hospital readmission (5.5% vs 8.0%, P = 0.03).

43 tations (10.8% v 13.8%; P = .2) or unplanned hospital readmissions (8.6% v 10.5%; P = .4) at 1 month.

44 (adjusted HR, 1.39 [95% CI, 1.23-1.56]) and hospital readmission (adjusted HR, 1.19 [95% CI, 1.11-1.

45 Reducing hospital readmission after acute myocardial infarction (

46 Hospital readmission after colorectal surgery is common,

47 Hospital readmission after lobectomy is associated with

48 Hospital readmission after pancreatic resection is commo

49 es was associated with an increased risk for hospital readmission after pancreatoduodenectomy.

50 rd can be used to refine risk prediction for hospital readmission after percutaneous coronary interve

51 Early hospital readmission after transplantation is common and

52 However, little is known about hospital readmissions after an influenza hospitalization

53 k factors, outcomes, and prevention of early hospital readmissions after kidney, liver, and kidney-pa

54 We confirmed that the majority of unplanned hospital readmissions after sepsis are due to an infecti

55 dence suggests that some, but not all, early hospital readmissions after transplantation may be preve

56 ssion (DHR) data, they may underestimate all-hospital readmission (AHR) rates (hospital A to hospital

57 The study outcomes included hospital readmission, all-cause mortality, and health ca

58 ght to understand the relative importance of hospital readmission among all health services received

59 f our study was to characterize frequency of hospital readmissions among patients hospitalized with l

60 cations highlighting the high rates of early hospital readmissions among transplant recipients, more

61 poor and there are few treatments to prevent hospital readmission and death.

62 The coprimary outcomes were all-cause hospital readmission and emergency department visits (tr

63 tions, length of hospital stay, and rates of hospital readmission and emergency department visits wit

64 ics, comorbidities, CMV disease coded during hospital readmission and inpatient death.

65 Frailty increases early hospital readmission and mortality risk among kidney tra

66 Overall rates of hospital readmission and serious adverse events were sim

67 survivors were followed for 1 year to assess hospital readmission and survival.

68 hospital system could save approximately 7.5 hospital readmissions and 253.8 hospital days per year.

69 Among 7 studies that examined hospital readmissions and avoidable initial hospitalizat

70 tivariate modeling approach that categorizes hospital readmissions and emergency department visits as

71 fficient option when analyzing heart failure hospital readmissions and emergency department visits.

72 ct clinical outcomes, resulting in increased hospital readmissions and higher long-term costs.

73 laboratory, and imaging data with number of hospital readmissions and in-hospital days over the next

74 g this high-risk group may decrease frequent hospital readmissions and increase access to transplanta

75 Heart failure-related hospital readmissions and mortality are often outcomes i

76 rogram decreases chronic heart failure (CHF) hospital readmissions and mortality over a six-month per

77 of stroke, poor functional status, increased hospital readmissions and substantial cognitive dysfunct

78 The potential for preventing early hospital readmissions and the impact on patient outcomes

79 Primary endpoints included hospital readmissions and total days readmitted.

80 Outpatient commitment can work to reduce hospital readmissions and total hospital days when court

81 Fifty-one (13%) donors required hospital readmission, and 14 (4%) required 2 to 5 readmi

82 ed return to the operating room and need for hospital readmission, and 8 minor wound-related complica

83 We compared mortality, hospital readmission, and changes in functional status i

84 ney disease, conversion to chronic dialysis, hospital readmission, and long-term mortality.

85 stay, cost of hospitalization, incidence of hospital readmission, and mortality for patients who did

86 acceptable perioperative complication rates, hospital readmission, and mortality rates.

87 ing in high rates of clinical complications, hospital readmissions, and death.

88 its with respect to hypertension management, hospital readmissions, and diabetic glycemic control.

89 tient outcomes following index and non-index hospital readmissions, and explore predictive factors fo

90 hour contact for patients, prior approval of hospital readmissions, and HBPC team participation in di

91 ed as 100-adherence rate), 30-day mortality, hospital readmissions, and Medicare spending across hosp

92 tal sign measurements, length of stay (LOS), hospital readmissions, and mortality.

93 AMI) and heart failure (HF), post-AMI and HF hospital readmissions, and mortality.

94 The magnitude of effect on LT outcomes, hospital readmissions, and QOL suggests that the adoptio

95 agement program (THMP) on patient adherence, hospital readmissions, and quality of life (QOL) after l

96 h nonaffective psychotic disorders, reducing hospital readmissions approximately 72% and requiring 28

97 Causes for early hospital readmission are most commonly due to surgical,

98 Hospital readmissions are believed to be an indicator of

99 Hospital readmissions are common after major surgery, al

100 Hospital readmissions are common and costly and, in some

101 Hospital readmissions are common and costly, and no sing

102 Hospital readmissions are common, costly, and potentiall

103 We assessed the risk of hospital readmission at 1 year, including measures of lo

104 cubitril/valsartan (LCZ696) reduces rates of hospital readmission at 30-days following HF hospitaliza

105 with care, and caregiver burden and reduced hospital readmissions at 6 months, but it did not substi

106 Outcome measures included patient mortality; hospital readmissions, avoidable admissions, and prolong

107 recurrent bloodstream infections, and 30-day hospital readmissions, but the AST intervention group ha

108 to reduce the absolute probability of 30-day hospital readmission by 3.5% (95% confidence interval, 1

109 We assessed mortality, hospital readmissions (categorized by ambulatory care se

110 dpoints were survival and inflation-adjusted hospital readmission charges.

111 antibodies were more likely to have multiple hospital readmissions compared to children with normal a

112 nts had slightly higher percentage (4.2%) of hospital readmissions compared to youth (3.4%, P = .01)

113 Different-hospital readmissions constituted 13.9% of 31,325 AHRs.

114 io = 0.56, 95% CI: 0.32, 0.96; p = 0.03) and hospital readmission costs of $7,515 less per patient.

115 between the two groups apart from 3.0 fewer hospital readmission days (95% CI, -5.3 to -0.8; p = 0.0

116 The number of planned hospital readmissions defined by the readmission measure

117 Because hospitals lack different-hospital readmission (DHR) data, they may underestimate

118 r 14 years, suggesting that as LOS improved, hospital readmission did not increase.

119 Different-hospital readmissions differentially affect hospitals' p

120 primary outcome measure was the incidence of hospital readmissions directly related to adhesions in t

121 We assessed mortality, hospital readmission, discharge to home, and logistic re

122 dministrative and clinical diagnoses for all hospital readmissions, discrepancy between planned readm

123 Five themes emerged as reasons cited for hospital readmission: distressing symptoms, unavoidable

124 Number of rejection episodes and hospital readmissions during the first posttransplantati

125 ter discharge included those attributable to hospital readmission, ED visits, rehab, physician billin

126 Early hospital readmission (EHR) after kidney transplantation

127 Early hospital readmission (EHR) is associated with increased

128 s studies investigating patients at risk for hospital readmissions focus on medical services and have

129 identification of patients at risk for early hospital readmission following KT may guide discharge pl

130 We calculated crude 30-day all-cause hospital readmissions following carotid revascularizatio

131 Hospital readmissions following surgery lead to worse pa

132 Five-year freedom from hospital readmission for CHF was 78%.

133 outcomes may be used to estimate the risk of hospital readmission for CHF.

134 hod for identifying an individual's risk for hospital readmission for congestive heart failure (CHF)

135 erapy was associated with increased rates of hospital readmission for diabetic complications traditio

136 ollow-up, all patients remain alive, without hospital readmission for heart failure and with New York

137 dy was to identify independent predictors of hospital readmission for patients undergoing lobectomy f

138 The primary outcome was one or more hospital readmissions for any reason or death from the t

139 as recently been focused on the reduction of hospital readmissions for COPD exacerbations, health sys

140 Hospital readmissions for heart failure (HF) contribute

141 ar composite outcome was all-cause death and hospital readmissions for myocardial infarction, heart f

142 ice visits, emergency department visits, and hospital readmissions for newborns.

143 Reducing hospital readmissions for patients with heart failure is

144 ly implemented financial penalties to reduce hospital readmissions for select conditions, including c

145 In contrast, among nonpenalty hospitals, readmissions for target conditions declined s

146 in admission (treat-and-release encounters), hospital readmissions from any source, and a combined me

147 Hospital readmission has been increasingly targeted as a

148 BACKGROUND DATA: Hospital readmission has been increasingly targeted as a

149 MI and HF in Ontario, Canada, where reducing hospital readmissions has not had a policy incentive.

150 Over the past 5 years, early hospital readmissions have become a national focus.

151 he United States, national efforts to reduce hospital readmissions have been enacted, including the a

152 Efforts to reduce hospital readmissions have focused primarily on improvin

153 , T patients had a significant lower rate of hospital readmission (hazard ratio: 0.64, p < 0.001) and

154 significantly associated with an increase in hospital readmission [hazard ratio (HR) = 1.63, 95% conf

155 ent outcomes, with a 32% lower likelihood of hospital readmission if the first inpatient unit was an

156 omes including delayed graft function, early hospital readmission, immunosuppression intolerance, and

157 y determined predictors of early nonelective hospital readmission in 92 (49 women and 43 men) nutriti

158 plex (OR, 3.5; 95% CI, 2.1-6.1) CHD, and for hospital readmission in both CHD groups combined (OR, 3.

159 To compare treatment failure leading to hospital readmission in children with complicated append

160 and validate a risk score to predict 30-day hospital readmission in decompensated cirrhosis patients

161 e severe exacerbations and increased risk of hospital readmission in patients with chronic obstructiv

162 with heart failure (HF) are at high risk for hospital readmission in the first 30 days following HF h

163 intestinal illnesses, failure to thrive, and hospital readmission in the first year of life and socio

164 onitoring by outpatient providers can reduce hospital readmissions in patients receiving hemodialysis

165 lease visits and 147.6 (95% CI, 147.3-147.9) hospital readmissions in the 30 days following discharge

166 Reducing hospital readmissions, including preventable healthcare-

167 ost data on readmission focus solely on same hospital readmission (index hospitals) within 30 days of

168 two regimens had similar toxicity profiles (hospital readmission, infection, wound complications, an

169 Early hospital readmission is a common and costly problem in t

170 Hospital readmission is a key marker of quality of healt

171 Early hospital readmission is also associated with decreased g

172 Hospital readmission is an important clinical outcome of

173 Early hospital readmission is an important metric for health c

174 This is important because hospital readmission is being used as a quality indicato

175 Hospital readmission is common after sepsis, yet the rel

176 Early hospital readmission is emerging as an indicator of care

177 Reduction of early hospital readmissions is a declared goal in the United S

178 One potential strategy for reducing early hospital readmissions is to critically examine care rece

179 y, admission to intensive care, non-elective hospital readmission, major complications, and decline i

180 A reduction in hospital readmissions may improve quality and reduce cos

181 ll, 10-year mortality was 98.8%, with 35 966 hospital readmissions occurring over the lifetime of the

182 Risk factors associated with early hospital readmission often reflect pretransplant comorbi

183 hospitalizations are frequently followed by hospital readmissions, often for recurrent sepsis.

184 that sustained outpatient commitment reduced hospital readmissions only when combined with a higher i

185 Hospital readmission or death occurred in 46% of patient

186 Independent factors influencing time to hospital readmission or death were identified.

187 The primary outcome was a composite of hospital readmission or death within 30 days of discharg

188 ber of diagnostic tests after infection, and hospital readmissions or visits to the emergency departm

189 nd age correlated with a lower likelihood of hospital readmission (OR = 0.94; P = 0.02).

190 of intubation, tracheostomy tube placement, hospital readmission, or mortality between patients with

191 Patients may experience multiple hospital readmissions over time with mortality acting as

192 alization had a significantly longer time to hospital readmission (P <.001) and improved survival (P

193 s of postoperative morbidity (P = 0.047) and hospital readmissions (P = 0.04) in the >/= 8 mug/mL com

194 9 readmissions/patient for control group) in hospital readmissions (P=.03) at 6 months that was not s

195 mpared with the worst-performing quartile of hospital readmission performance, there was a significan

196 Complicated PPS--noncomplicated PPS plus hospital readmission +/- pericardiocentesis or thoracent

197 le emergency department (ED) utilization and hospital readmissions pose a significant economic burden

198 Current approaches ascribe variability in hospital readmission primarily to differences in patient

199 optimized, had a significantly lower rate of hospital readmissions, primarily because of fewer heart

200 The reduction in 30-day hospital readmission ranged from 0.5% to 4.9% in an addi

201 In a risk-adjusted hospital readmission rate analysis, hospitals that disch

202 interventions, from 2011 to 2015, the index hospital readmission rate has declined from 9.6% to 5.3%

203 ate whether hemodynamic optimization reduces hospital readmission rate in LVAD patients.

204 Hospital readmission rate is receiving increasing regula

205 ned ED utilization rate was 11.3% and 30-day hospital readmission rate was 5.3%.

206 The total hospital readmission rate was lower in the optimized gro

207 Endpoints were THMP participation, 90-day hospital readmission rate, and QOL.

208 d hospital discharge within 23 hours, 30-day hospital readmission rate, early (<30 day) and late comp

209 functional status were associated with lower hospital readmission rates across the 6 impairment categ

210 Little risk-adjusted variation exists in hospital readmission rates after colorectal surgery.

211 rent efforts to improve health care focus on hospital readmission rates as a marker of quality and on

212 alth care systems, payers, and hospitals use hospital readmission rates as a measure of quality.

213 ospital-level variation among regional index hospital readmission rates as an instrument, instrumenta

214 Hospital readmission rates following surgery are increas

215 rvices (CMS) began publicly reporting 30-day hospital readmission rates for patients discharged with

216 Risk-standardized 30-day mortality and hospital readmission rates for pneumonia are increasingl

217 The 90-day hospital readmission rates for those with ABSSSIs may be

218 Reducing hospital readmission rates is a national priority; howev

219 is not associated with an increase in 30-day hospital readmission rates or wound complications when c

220 The release of the CMS public reporting of hospital readmission rates was not associated with any m

221 length of stay was 4 days shorter and 30-day hospital readmission rates were 48% lower in the exebaca

222 Hospital readmission rates were similar for those discha

223 -called day-case care bundles to reduce high hospital readmission rates with greater care in the comm

224 Hospital readmission rates within 30 days after acute my

225 admissions, length of hospital stay, 30-day hospital readmission rates, and emergency department use

226 nia also had higher 30-day mortality, 30-day hospital readmission rates, and hospital spending per pa

227 ransplant recipients from the calculation of hospital readmission rates, the outcome of their advocac

228 is still associated with high mortality and hospital readmission rates.

229 al LOS that were accompanied by increases in hospital readmission rates.

230 spital mortality, discharge disposition, and hospital readmission rates.

231 Services recently started publicly reporting hospital readmission rates.

232 ion rates, discharge destination, and 30-day hospital readmission rates.

233 Patients with cirrhosis have high hospital readmissions rates but the relationship between

234 Reducing hospital-readmission rates is a clinical and policy prio

235 solate hospital effects on risk-standardized hospital-readmission rates, we examined readmission outc

236 We also determined hospitals readmissions rates and healthcare utilization

237 For penalty hospitals, readmission rates for target conditions decli

238 was by telephone or review of outpatient or hospital readmission records.

239 and Medicaid Services (CMS) will expand its Hospital Readmission Reduction Program (HRRP) to include

240 ion rates declined after announcement of the Hospital Readmission Reduction Program (HRRP), which pen

241 To understand the impact of the Hospital Readmission Reduction Program on both future ta

242 o assess the rates of readmission before the Hospital Readmission Reduction Program was announced (20

243 The Hospital Readmission Reduction Program, established unde

244 ing to financial incentives announced in the Hospital Readmission Reduction Program.

245 icare's value-based purchasing (VBP) and the Hospital Readmissions Reduction Program (HRRP) could dis

246 The Hospital Readmissions Reduction Program (HRRP) has been

247 The Hospital Readmissions Reduction Program (HRRP) has penal

248 st improvement after passage of the Medicare Hospital Readmissions Reduction Program (HRRP) is unknow

249 st improvement after passage of the Medicare Hospital Readmissions Reduction Program (HRRP) is unknow

250 pared using the CMS Hospital Compare and the Hospital Readmissions Reduction Program (HRRP) methodolo

251 The Hospital Readmissions Reduction Program (HRRP) was estab

252 es centers subject to the first cycle of the Hospital Readmissions Reduction Program between July 1,

253 al penalties were projected according to the Hospital Readmissions Reduction Program formula using on

254 The Medicare Hospital Readmissions Reduction Program has led to fewer

255 r, respectively, until implementation of the Hospital Readmissions Reduction Program in October 2012

256 S Centers for Medicare and Medicaid Services Hospital Readmissions Reduction Program penalizes hospit

257 The Hospital Readmissions Reduction Program penalizes hospit

258 Medicare's Hospital Readmissions Reduction Program reports risk-sta

259 The Hospital Readmissions Reduction Program will potentially

260 During the first cycle of the Hospital Readmissions Reduction Program, participating h

261 The Hospital Readmissions Reduction Program, which is includ

262 nited States since the implementation of the Hospital Readmissions Reduction Program.

263 th above-average readmission rates under the Hospital Readmissions Reductions Program.

264 Hospital readmissions represent an important burden in t

265 ased mortality, discharge to long-term care, hospital readmission, resource utilization, and costs.

266 This makes early prediction of the hospital readmission risk an important problem.

267 Predicting hospital readmission risk is of great interest to identi

268 h November 30, 2009, to identify 30-day same-hospital readmissions (SHRs), DHRs, and AHRs.

269 Infection-related hospital readmissions, specifically, were more likely in

270 rce, and a combined measure of ED visits and hospital readmissions termed hospital-based acute care.

271 ong-term mortality, recurrent pneumonia, and hospital readmission, the few reported studies suggest t

272 Of the 315 hospital readmissions, the readmission diagnosis listed

273 This study examined predictors of hospital readmission to determine whether readmissions c

274 tcomes of interest (involuntary admission to hospital, readmission to hospital, and inpatient bed day

275 ondary outcomes were number of reoperations, hospital readmissions, total length of hospital stay dur

276 justed HR, 3.2; 95% CI, 1.3-7.8), and 30-day hospital readmission (unadjusted HR, 3.2; 95% CI, 2.0-5.

277 Assessment of 30 day same hospital readmissions underestimated the true incidence

278 nical medical record review, and fraction of hospital readmissions unrelated to the original hospital

279 gnosis-specific, and potentially preventable hospital readmissions using McNemar's chi-square tests f

280 dict readmission risk and explore sources of hospital readmission variation.

281 nt for baseline characteristics, the rate of hospital readmission was 20.5% in women and 11.0% in men

282 Early hospital readmission was defined as readmission to hospi

283 s hospitalized with CHF at increased risk of hospital readmission were randomized to a multidisciplin

284 rates, prolonged hospital stay, and rates of hospital readmission were significantly reduced.

285 vs. 59, 11%; P = 0.11), length of stay, and hospital readmission were similar in both groups.

286 Reoperations and hospital readmissions were adjudicated by independent re

287 The frequency and cause of hospital readmissions were compared between patients who

288 ADR-related hospital readmissions were similar in both groups (2.1 a

289 cal site infection, anastomotic leakage, and hospital readmission when compared to no preoperative bo

290 gan dysfunction, mortality, reoperation, and hospital readmission, with estimated population attribut

291 ith increased resource utilization including hospital readmissions, with many due to an ambulatory ca

292 The primary outcome was hospital readmission within 180 days after discharge.

293 % CI 1.10-1.47), a 54% increase in odds of a hospital readmission within 30 days (95% CI 1.25-2.88),

294 ov 15, 2011, we assessed patients who needed hospital readmission within 30 days after open abdominal

295 ion, 409 (14%) and 1364 (47%) had at least 1 hospital readmission within 30 days and 1 year of the in

296 discharge), time to hospital discharge, and hospital readmission within 30 days of discharge.

297 Emory OPAT clinic would reduce the risk for hospital readmission within 30 days.

298 Hospital readmissions within 30 days of discharge follow

299 ociated with emergency department visits and hospital readmissions within 30 days of discharge.

300 absolute rates of adverse outcomes, such as hospital readmission, worsening functional status, and w